Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Heart failure

Interatrial shunting for the treatment of heart failure

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Del Trigo, M. et al. Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study. Lancet 387, 1290–1297 (2016)

    Article  Google Scholar 

  2. Hasenfuß, G. et al. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet 387, 1298–1304 (2016)

    Article  Google Scholar 

Download references

Authors

Related links

Related links

Related links in Nature Research

Borlaug, B. A. The pathophysiology of heart failure with preserved ejection fraction. Nat. Rev. Cardiol. 11, 507–515 (2014)

Ziaeian,B.&Fonarow,G.C.Epidemiologyandaetiologyofheartfailure.Nat.Rev.Cardiol.http://dx.doi.org/10.1038/nrcardio.2016.25(2016)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fernández-Ruiz, I. Interatrial shunting for the treatment of heart failure. Nat Rev Cardiol 13, 312–313 (2016). https://doi.org/10.1038/nrcardio.2016.56

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2016.56

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing